7611 - 7620 of 8620 Results
Title
Year
- Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease2005RESTRICTEDTitle: Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 19Issue #: 14Start Page: 2040End Page: 2041Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.05-3735fjeCitation Count: 720
- Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease2020OPENTitle: Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s diseaseJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 43Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.aaz9360Best OA location URL: https://advances.sciencemag.org/content/advances/6/43/eaaz9360.full.pdfCitation Count: 282
- Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease2006RESTRICTEDTitle: Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 20Issue #: 3Start Page: 419End Page: 425Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.03-1449comCitation Count: 692
- Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes2019OPENTitle: Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromesJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 90Issue #: 7Start Page: 768End Page: 773Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2018-320151Best OA location URL: https://jnnp.bmj.com/content/jnnp/90/7/768.full.pdfCitation Count: 49
-
OPENTitle: Deep gray matter volume loss drives disability worsening in multiple sclerosisJournal Name: Annals of NeurologyPublisher: WileyVol: 83Issue #: 2Start Page: 210End Page: 222Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/ana.25145Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/e17312df-ef70-416a-a782-0c33bcbef599Citation Count: 374
- Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect ofl‐DOPAtreatment and changes in levodopa‐induced dyskinesia2017OPENTitle: Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect ofl‐DOPAtreatment and changes in levodopa‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 141Issue #: 4Start Page: 614End Page: 625Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.13997Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13997Citation Count: 40
- Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry Approach to Correlate Local Structure and Aggregation in α-Synuclein2022OPENTitle: Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry Approach to Correlate Local Structure and Aggregation in α-SynucleinJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 94Issue #: 48Start Page: 16711End Page: 16719Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.analchem.2c03183Best OA location URL: https://doi.org/10.1021/acs.analchem.2c03183Citation Count: 18
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup2024OPENTitle: Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 8Start Page: 5143End Page: 5169Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.13859Best OA location URL: https://hdl.handle.net/11380/1365841Citation Count: 616
- Ultra‐low‐dose PET reconstruction using generative adversarial network with feature matching and task‐specific perceptual loss2019OPENTitle: Ultra‐low‐dose PET reconstruction using generative adversarial network with feature matching and task‐specific perceptual lossJournal Name: Medical PhysicsPublisher: WileyVol: 46Issue #: 8Start Page: 3555End Page: 3564Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mp.13626Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6692211Citation Count: 159
- M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress Disorder2019OPENTitle: M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress DisorderJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 989End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.biopsych.2019.02.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6555658Citation Count: 33